Progyny
PGNY · NASDAQ
$28.58+$0.74 (+2.66%)TodayMarket closed ·
Prev close $27.84
About PGNY
- Employees
- 856
- Headquarters
- New York City, New York
- Listed
- Oct 25, 2019
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Website
- progyny.com
Leadership
| Name | Title | Since |
|---|---|---|
| David Schlanger | — | 2017 |
| Michael Sturmer | — | — |
| Peter Anevski | — | 2017 |
| Mark Livingston | — | — |
| Melissa Cummings | — | — |
| Allison Swartz | — | — |
| Geoffrey Clapp | — | — |
| Jeffrey Park | — | — |
| Lloyd Dean | — | — |
| Kevin Gordon | — | — |
| Roger Holstein | — | — |
| Debra Morris | — | — |
| Norman Payson | — | — |
| Cheryl Scott | — | — |
Revenue by product and region
Fiscal year ended Dec 31, 2025: $1.29B total revenue
By product
- Fertility benefit services revenue$830.93M64.5%
- Pharmacy benefit services revenue$457.73M35.5%
Similar companies
Companies in the same industry as Progyny
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.